Cara Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy CARA

*Your capital is at risk

$5.32

+0 (+0%)

At Close: Jul 14, 2025

Currently predicting for Fri, 5 Jun 2026

CARA Prediction Chart

CARA Predictions History

Latest community submissions for CARA.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
mapeki @mapeki.1341	Oct 25, 2016	$7.00 -97.41%	$7.51	V	93.20%	0
JS Pro	Oct 25, 2016	$7.68 -97.16%	$7.51	V	97.70%	0
JS Pro	Oct 6, 2016	$10.25 -96.81%	$8.92	X	85.10%	0
Sean.Yang.1188	Oct 6, 2016	$10.22 -96.82%	$8.92	X	85.40%	0
PumpTheseNumbers Pro	Sep 23, 2016	$7.30 -97.23%	$7.33	V	99.60%	4
JS Pro	Sep 23, 2016	$7.12 -97.30%	$7.33	V	97.10%	0
StockInvest Amateur	Aug 9, 2016	$5.96 -97.26%	$6.04	V	98.70%	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CARA with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT CARA THERAPEUTICS

Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and immune cells. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of mod...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by